Gardner Lewis Asset Management L P Dexcom Inc Transaction History

Gardner Lewis Asset Management L P

$353 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $119,365 - $191,308	1,387 Added 7.66%	19,489 $1.82 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $247,312 - $292,303	2,378 Added 15.12%	18,102 $2.1 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $1.34 Million - $1.93 Million	15,724 New	15,724 $1.78 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $2.7 Million - $5.28 Million	39,767 Added 311.92%	52,516 $3.91 Million
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $17,792 - $22,306	-137 Reduced 1.06%	12,749 $6.85 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $98,173 - $131,725	-920 Reduced 6.66%	12,886 $7.05 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $67,577 - $83,477	-797 Reduced 5.46%	13,806 $4.96 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $296,868 - $397,727	-3,806 Reduced 20.67%	14,603 $5.4 Million
Q3 2020 Nov 09, 2020	SELL	$95.51 - $112.95 $128,938 - $152,482	-1,350 Reduced 6.83%	18,409 $7.59 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $125,046 - $210,153	-1,995 Reduced 9.17%	19,759 $8.01 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $180,072 - $284,973	-3,768 Reduced 14.76%	21,754 $5.86 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $10,949 - $17,129	-299 Reduced 1.16%	25,522 $5.58 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $139,668 - $172,177	3,931 Added 17.96%	25,821 $3.85 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $10,440 - $14,595	-375 Reduced 1.68%	21,890 $3.28 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $624,978 - $850,077	22,265 New	22,265 $2.65 Million

Others Institutions Holding DXCM

# of Institutions

1,035

Shares Held

353M

Call Options Held

5.51M

Put Options Held

5.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.

Account